Sriram Sai, Root Kevin, Chacko Kevin, Patel Aashay, Lucke-Wold Brandon
Department of Neurosurgery, University of Florida, Gainesville, FL 32608, USA.
Biomedicines. 2022 Oct 21;10(10):2657. doi: 10.3390/biomedicines10102657.
Synucleinopathies represent a diverse set of pathologies with significant morbidity and mortality. In this review, we highlight the surgical management of three synucleinopathies: Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). After examining underlying molecular mechanisms and the medical management of these diseases, we explore the role of deep brain stimulation (DBS) in the treatment of synuclein pathophysiology. Further, we examine the utility of focused ultrasound (FUS) in the treatment of synucleinopathies such as PD, including its role in blood-brain barrier (BBB) opening for the delivery of novel drug therapeutics and gene therapy vectors. We also discuss other recent advances in the surgical management of MSA and DLB. Together, we give a diverse overview of current techniques in the neurosurgical management of these pathologies.
突触核蛋白病是一组具有显著发病率和死亡率的多种病理状况。在本综述中,我们重点介绍三种突触核蛋白病的外科治疗:帕金森病(PD)、路易体痴呆(DLB)和多系统萎缩(MSA)。在研究这些疾病的潜在分子机制和药物治疗后,我们探讨了深部脑刺激(DBS)在治疗突触核蛋白病理生理学中的作用。此外,我们研究了聚焦超声(FUS)在治疗如PD等突触核蛋白病中的效用,包括其在打开血脑屏障(BBB)以递送新型药物治疗和基因治疗载体方面的作用。我们还讨论了MSA和DLB外科治疗方面的其他最新进展。我们共同对这些病理状况的神经外科治疗中的当前技术进行了全面概述。